<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: : An association between <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> appears to exist on the basis of reported anecdotal cases in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: : To determine the prevalence of <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> associated with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> in inpatients and to identify the demographic and clinical features of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> that may be unique when associated with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: : In this observational study, we analyzed data from the Nationwide Inpatient Sample between 2002 and 2009 using International Classification of Diseases codes for <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> for patient identification </plain></SENT>
<SENT sid="3" pm="."><plain>Data including patient age, sex, race/ethnicity, secondary diagnosis, procedures, hospital costs, and patient outcomes were obtained </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: : From 2002 to 2009, an estimated 518 patients (mean ± SD age, 16.2 ± 1.68 years) with coexisting <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> were admitted </plain></SENT>
<SENT sid="5" pm="."><plain>The estimated prevalence was 3.8% (3760 per 100 000) among patients admitted with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and 9.5% (9540 per 100 000) among <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> patients &lt; 15 years of age </plain></SENT>
<SENT sid="6" pm="."><plain>Patients admitted with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> were most frequently white and Hispanic (P = .02) </plain></SENT>
<SENT sid="7" pm="."><plain>They were more likely to present with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and less commonly with hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> (15.3% and 2.7%, respectively; P &lt; .05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: : This is the first study to estimate the prevalence of <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> in patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The 26-fold-greater prevalence of <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> in patients with coexisting <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> compared with the prevalence of <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> among live births (145 per 100 000) highlights the need for a better understanding of the common pathophysiology of the 2 conditions </plain></SENT>
<SENT sid="10" pm="."><plain>ABBREVIATIONS: : <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>-9-CM, International Classification of Disease, Ninth Revision, Clinical ModificationNIS, Nationwide Inpatient Sample </plain></SENT>
</text></document>